The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
Advanced image-free robotic platform to support greater precision, personalised planning, and improved patient outcomes
The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
Healthcare operations veteran with over 23 years of experience to lead key initiatives across South India
The upgraded Rajajipuram centre now features enhanced retina services and advanced OCT technology
Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
Subscribe To Our Newsletter & Stay Updated
